![]() |
Volumn 44, Issue 1-4, 2002, Pages 3-7
|
Recent aspects of pharmaceutical application of cyclodextrins
|
Author keywords
Controlled drug release; Cyclodextrin derivative; Drug carrier; Pharmaceutical application; Site specific drug delivery
|
Indexed keywords
2 HYDROXYPROPYL BETA CYCLODEXTRIN;
2,6 O DIMETHYL BETA CYCLODEXTRIN;
ALPHA CYCLODEXTRIN DERIVATIVE;
ANTIINFLAMMATORY AGENT;
BETA CYCLODEXTRIN DERIVATIVE;
BETA CYCLODEXTRIN SULFOBUTYL ETHER;
CHLORAMPHENICOL PALMITATE;
CYCLOSPORIN A;
DENDRIMER;
EXCIPIENT;
FELBINAC;
GAMMA CYCLODEXTRIN DERIVATIVE;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
ITRACONAZOLE;
LIPOFECTIN;
MALTOSYL BETA CYCLODEXTRIN;
NIFEDIPINE;
ONO 4819;
PEPTIDE;
PLASMID DNA;
POLYAMIDOAMINE;
POVIDONE IODINE;
PREDNISOLONE HEMISUCCINATE;
PRODRUG;
PROSTAGLANDIN E1 DERIVATIVE;
PROTEIN;
TOLBUTAMIDE;
TRANSFAST;
TSUKUBAENOLIDE;
UNCLASSIFIED DRUG;
CHEMICAL MODIFICATION;
COMPLEX FORMATION;
CONFERENCE PAPER;
CRYSTALLIZATION;
DRUG BIOAVAILABILITY;
DRUG CONJUGATION;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
GENE THERAPY;
GENETIC POLYMORPHISM;
NONHUMAN;
NONVIRAL GENE THERAPY;
SMALL INTESTINE;
STOMACH;
VIRAL GENE THERAPY;
|
EID: 0347657028
PISSN: 09230750
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1023007032444 Document Type: Conference Paper |
Times cited : (84)
|
References (32)
|